4-Pro-MET carries a risk profile covering both physical and psychological side effects reported by community researchers. No controlled clinical safety data exist for this compound ? everything here comes from community reports, structural analogy to better-studied tryptamines, and general serotonergic pharmacology. We've catalogued the known side effects, assessed their severity and frequency, and flagged the safety gaps that matter most.

Physical side effects of 4-Pro-MET are generally mild to moderate, consistent with the serotonergic pharmacology of its active metabolite 4-HO-MET.

Commonly Reported (>30% of reports)

• Pupil dilation (mydriasis): Nearly universal with serotonergic psychedelics. Occurs at all active dose levels.
• Onset nausea: Reported by approximately 30-40% of community researchers, typically resolving within 30-60 minutes. More common on an empty stomach or with pellet forms that dissolve in the stomach
• Elevated heart rate: Mild tachycardia (increase of 10-20 BPM) attributed to sympathomimetic effects of 5-HT2A activation

Occasionally Reported (10-30%)

• Temperature sensitivity: Feeling unusually warm or cold, difficulty regulating body temperature
• Jaw tension / bruxism: Clenching or grinding, especially at higher doses
• Headache: Sometimes shows up during the comedown phase
• Blood pressure elevation: Mild and transient, but worth watching if you have pre-existing cardiovascular conditions

Rarely Reported (<10%)

• Vomiting: Uncommon; more associated with very high doses
• Tremors: Fine motor tremor at high doses
• Muscle tension: Generalized body tightness

Community reports consistently describe 4-Pro-MET / 4-HO-MET as having lower body load (overall physical discomfort) compared to psilocybin mushrooms. This likely reflects the synthetic compound's higher purity and the absence of other alkaloids found in mushroom preparations.

Psychological side effects are dose-dependent. Set (mental state) and setting (physical environment) shape them heavily.

At Standard Doses (10-15 mg)

The "clear headspace" that defines MET-series tryptamines means cognitive impairment and distress are less common at standard doses than with DMT-series compounds. That said, come-up anxiety is reported by approximately 15-25% of researchers, especially first-time users. It usually resolves once peak effects stabilize.

At High Doses (>25 mg)

The experience changes drastically above 25-30 mg. Community reports consistently warn of confusion, thought loops (repetitive cycling through the same thoughts), paranoid anxiety, depersonalization, and derealization. And these effects become far more likely in uncomfortable settings or negative mental states.

Potential Long-Term Psychological Risks

• HPPD (Hallucinogen Persisting Perception Disorder): Persistent visual disturbances (visual snow, halos, trailing) after psychedelic use. Incidence estimated at 0.1-4.2% of psychedelic users. No specific data for 4-Pro-MET.
• Psychiatric destabilization: Individuals with personal or family history of psychotic disorders face elevated risk. This contraindication applies to all serotonergic psychedelics.

Several safety parameters remain unknown for 4-Pro-MET. The gaps are real:

• No LD50 value: The lethal dose has not been established for 4-Pro-MET or 4-HO-MET in any animal model
• No long-term toxicity data: Chronic effects on organs, particularly the heart and liver, are unknown
• 5-HT2B cardiac risk: Binding data from 4-PrO-DMT show high affinity at 5-HT2B (Ki = 17 nM). Chronic 5-HT2B agonism is linked to cardiac valve fibrosis, as documented with fenfluramine and ergotamine. How relevant this is for intermittent tryptamine use? Unknown, but theoretically concerning.
• No cardiovascular safety profile: Effects on QT interval, cardiac contractility, and blood pressure under controlled conditions haven't been measured